We previously identified structurally diverse small molecule (non-peptidic) inhibitors (SMNPIs) of thebotulinum neurotoxin serotype A (BoNT/A) light chain (LC). Of these, several (including antimalarial drugs)contained a 4-amino-7-chloroquinoline (ACQ) substructure and a separate positive ionizable amine component.The same antimalarials have also been found to interfere with BoNT/A translocation into neurons, via pHelevation of the toxin-mediated endosome. Thus, this structural class of small molecules may serve as dual-function BoNT/A inhibitors. In this study, we used a refined pharmacophore for BoNT/A LC inhibition toidentify four new, potent inhibitors of this structural class (IC
50's ranged from 3.2 to 17
![](/images/entities/mgr.gif)
M). Moleculardocking indicated that the binding modes for the new SMNPIs are consistent with those of other inhibitorsthat we have identified, further supporting our structure-based pharmacophore. Finally, structural motifs ofthe new SMNPIs, as well as two structure-based derivatives, were examined for activity, providing valuableinformation about pharmacophore component contributions to inhibition.